Last reviewed · How we verify
Dutasteride and Tamsulosin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Dutasteride and Tamsulosin (Dutasteride and Tamsulosin) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dutasteride and Tamsulosin TARGET | Dutasteride and Tamsulosin | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dutasteride and Tamsulosin CI watch — RSS
- Dutasteride and Tamsulosin CI watch — Atom
- Dutasteride and Tamsulosin CI watch — JSON
- Dutasteride and Tamsulosin alone — RSS
Cite this brief
Drug Landscape (2026). Dutasteride and Tamsulosin — Competitive Intelligence Brief. https://druglandscape.com/ci/dutasteride-and-tamsulosin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab